Definitive Contract W81XWH20C0145
Award Date
9/30/20
Potential Completion Date
9/29/25
Potential Value
$1.3M
Federal Agency
Defense Health Agency
Awardee
Green Mountain Antibodies Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Burlington, VT 05401, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the Department of Health and Human Services, to Green Mountain Antibodies Inc. for $22,300.00. The contract is for the delivery of antibody products and has an ultimate completion date of September 30, 2012. There is no set-aside designation mentioned. Green Mountain Antibodies Inc. is a for-profit manufacturer of goods organized as a Subchapter S...
The Defense Health Agency awarded a $84,720.53 firm fixed price purchase order to Genovac Antibody Discovery LLC, a small disadvantaged business, for the generation of monoclonal antibodies targeting ferret immunoglobulin M and immunoglobulin G. This requirement was solicited as a 100% small business set-aside. The contract has an ultimate completion date of December 29, 2023 and was awarded on May 1, 2023. The contract was issued under a federal contract opportunity posted on April 7, 2023 with...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to Green Mountain Antibodies Inc., a for-profit organization that manufactures goods and is structured as a Subchapter S Corporation. The $4,200.00 firm fixed price purchase order is for the production of antibodies from 4 cell lines with fluorescein labeling. The place of performance is in Burlington, Vermont, and the...
This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The contract is for the preparation of monoclonal antibodies against the MARCH1 protein, with a ceiling value of $16,900.00 and a performance period through July 31, 2025. A&G Pharmaceutical is a for-profit manufacturer of biological...
This is a $3,010,545.01 firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Integrum Scientific LLC, a self-certified small disadvantaged business, for blood collection and database creation services. The contract supports the development of monoclonal antibody therapeutics and evaluation of the immune responses in survivors of Marburg Virus disease (MVD) outbreaks in Uganda and Venezuelan Equine Encephalitis (VEE) outbreaks in Panama. The contractor will...
This is a definitive contract awarded by the Defense Health Agency (DHA) to Envigo Global Services Inc., a subsidiary of Envigo RMS Holding Corp. The contract, valued at $1,089,778.82, is for non-personal support services with a completion date of September 30, 2016. The contract is a firm fixed-price agreement and was not set aside for any particular business type. Envigo Global Services Inc. is a manufacturer of goods and provider of nonclinical and analytical drug discovery and development...
This is a $575,850.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract was awarded to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract is for unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. As a prime...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
The National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services, awarded a $18,500 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for laboratory testing, fusion, and cloning services. The contract has an ultimate completion date of November 30, 2024 and does not have a set-aside designation. This award is part of a larger $100 million Blanket Purchase Agreement (BPA)...